-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Palpation by blind examiners: A novel approach for glaucoma screening
Commentary
(2083) Views (742) Full article downloads
Authors: Fatemeh Heidary, Reza Gharebaghi, Roghayeh Heidary
Published Date July 2010
Volume 2010:4 Pages 671 - 672
DOI: http://dx.doi.org/10.2147/OPTH.S11167
Fatemeh Heidary, Reza Gharebaghi, Roghayeh HeidaryMiddle East Cancer Institute, Tehran, Iran
Abstract: Although there are several risk factors for glaucoma, elevated intraocular pressure (IOP) remains the major risk factor. Palpation is one of the oldest, simplest, and least expensive methods for approximate IOP assessment. Researchers believe that blind individuals may possess a more acutely developed sense of touch, which has already proved to be beneficial in clinical breast examination to detect early breast cancer. Based on successful findings of a project that used blind and visually impaired individuals as breast examiners, we hypothesize that blind individuals may also serve as successful examiners for estimation of IOP using tactile palpation.
Keywords: tactile palpation, visual impairment, blindness, intraocular pressure
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia
- Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%




